ArticleClinical and experimental immunology2022

Discovery of efficacy biomarkers for non-small cell lung cancer with first-line anti-PD-1 immunotherapy by 
data-independent acquisition mass spectrometry.

Yencheng Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.